Abbott Laboratories (BSP:ABTT34) Net Issuance of Debt : R$-4,133 Mil (TTM As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Abbott Laboratories Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Abbott Laboratories's net issuance of debt for the three months ended in Sep. 2024 was R$238 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2024 was R$-4,133 Mil.

Abbott Laboratories Net Issuance of Debt Historical Data

The historical data trend for Abbott Laboratories's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Net Issuance of Debt Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

-6,563.10

-257.24

-1,402.42

-3,666.54

-12,127.01

Abbott Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Issuance of Debt	Get a 7-Day Free Trial															-7,437.68	-4,600.91	-632.44	861.78	238.13

Abbott Laboratories Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-4,133 Mil.

Abbott Laboratories Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BSP:ABTT34) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico ABLd:UK ABL:Germany ABL:Germany ABL:Germany ABL:Germany ABL:Bulgaria ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories Headlines

No Headlines